510(k) K013568
K013568 is an FDA 510(k) premarket notification submitted by Bayer Corp. for the device "CEA ASSAY FOR THE ADVIA INTEGRATED MODULAR SYSTEM". The FDA issued a decision of Substantially Equivalent on December 21, 2001. The device falls under product code DHX (System, Test, Carcinoembryonic Antigen), a Class II device regulated under 21 CFR 866.6010. Bayer Corp. has at least 10 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- December 21, 2001
- Date Received
- October 26, 2001
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- System, Test, Carcinoembryonic Antigen
- Device Class
- Class II
- Regulation Number
- 866.6010
- Review Panel
- IM
- Submission Type